Načítá se...
Development of Radioimmunotherapeutic and Diagnostic Antibodies: An Inside-Out View
Only a handful of radiolabeled antibodies (Abs) have gained FDA approval for use in clinical oncology, including four immunodiagnostic agents and two targeted radioimmunotherapeutic agents. Despite the advent of non-immunogenic Abs and availability of a diverse library of radionuclides, progress bey...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2212602/ https://ncbi.nlm.nih.gov/pubmed/17921028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2007.04.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|